EVH PEER ANALYSIS

Evolent Health Inc — metric-by-metric comparison with peers and the industry median

EVHEvolent Health Inc

🇺🇸 USA · NYSE · Healthcare · Health Information Services

Value itDuel

Overall Profile & Returns

· Health Information Services

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial HealthDividend
EVHIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
EVH-51.3%FONET+128.7%PME-31.5%
Year-to-Date (YTD)
EVH+42.8%FONET+88.2%PME-4.8%

Key Metric Comparison

P/E

Lower is better
EVHFONET20.21PME93.49Median 41.96

ROE

Higher is better
EVH-74.6%FONET15.6%PME76.8%Median 2.7%

Net Margin

Higher is better
EVH-26.3%FONET26.0%PME97.6%Median 1.5%

Revenue Growth

Higher is better
EVH-21.3%FONET53.5%PME30.3%Median 7.1%

All Metrics

Valuation
MetricEVHFONETPMEInd. Median
P/E20.2193.4941.96
P/B1.612.6256.422.50
EV/EBITDA10.38115.2416.12
P/S0.345.2691.212.35
Financial Health
MetricEVHFONETPMEInd. Median
Current Ratio1.322.316.221.83
Debt/Equity248.6%2.5%1.1%22.0%
NetDebt/EBITDA-2.61-0.21-1.16-0.01
Profitability
MetricEVHFONETPMEInd. Median
Net Margin-26.3%26.0%97.6%1.5%
ROE-74.6%15.6%76.8%2.7%
ROA-21.9%13.2%56.7%1.4%
EBITDA Margin-16.7%49.6%78.4%12.4%
Growth + Dividend
MetricEVHFONETPMEInd. Median
Rev. Growth-21.3%53.5%30.3%7.1%
NI Growth26.6%138.8%23.6%
Div. Yield1.0%0.0%0.3%0.7%
Payout-1.3%0.0%24.5%9.6%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on EVH

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.